Search results
Results from the WOW.Com Content Network
The American Heart Association (AHA) and American Stroke Association (ASA) assist with research and data guidelines. The groups recently published the “2024 Guideline for the Primary Prevention ...
The American Heart Association (AHA) is a nonprofit organization in the United States that funds cardiovascular medical research, educates consumers on healthy living and fosters appropriate cardiac care in an effort to reduce disability and deaths caused by cardiovascular disease and stroke.
More than 795,000 people in the U.S. have a stroke each year, which is a leading cause of serious long-term disability. Many of the leading risk factors for stroke are modifiable, making ...
Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research ...
Stroke is a peer-reviewed medical journal published monthly by Lippincott Williams & Wilkins on behalf of the American Heart Association. It covers research on cerebral circulation and related diseases, including clinical research on assessment of risk for stroke , diagnosis, prevention, and treatment, as well as rehabilitation. [ 1 ]
"2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". Journal of the American College of Cardiology. 63 (25 Part B). American College of Cardiology: 2889– 3734.
Current guidelines recommend antiplatelet therapy for patients with non-cardioembolic ischemic stroke. [ 8 ] [ 9 ] [ 10 ] However, it is widely believed that there is a substantial overlap between ESUS and cardioembolic stroke, clinical trials have assessed the benefit of anticoagulation versus antiplatelet agents for preventing recurrent stroke.
In 2017, results of the CANTOS trial demonstrated that anti-inflammatory therapies reduce risk for heart attack, stroke, other cardiovascular events [10] and cancer by up to 50%. The method ties results of this testing to considerations of lifestyle, diet, sleep disorders , stress levels, genetic factors, and dental care, and personalized ...